Inactive Instrument
Poseida Therapeutics, Inc. Share Price
Stocks
PSTX
US73730P1084
Biotechnology & Medical Research
| 1 day | -0.63% |
| 3 years | 1.83 |  | 9.67 |
| 5 years | 1.54 | | 9.67 |
| 10 years | 1.54 | | 17.62 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dara Pincas
CEO | Chief Executive Officer | - | - |
Johanna Mylet
DFI | Director of Finance/CFO | 39 | 01/07/2020 |
Syed Rizvi
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sean Johnston
BRD | Director/Board Member | - | 08/01/2025 |
Roger Brown
BRD | Director/Board Member | - | 08/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/01/25 | Tender | Director | 1,90,300 | 0.1952% | ||
| 08/01/25 | Tender | Director | 1,41,500 | 0.1452% | ||
| 08/01/25 | Tender | Company | 1,18,35,673 | 12.1435% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | -.--% | - | - | 93Cr | |
| +2.41% | +0.29% | +39.41% | +72.14% | 6.47TCr | |
| -0.15% | +7.50% | +11.42% | +71.27% | 5.48TCr | |
| +0.57% | +4.60% | +7.71% | +90.93% | 5.35TCr | |
| +0.37% | +4.67% | +26.68% | +49.64% | 4.6TCr | |
| -1.21% | +2.32% | +21.50% | +118.33% | 4.29TCr | |
| -0.37% | +5.07% | +243.23% | +789.58% | 4.01TCr | |
| +0.05% | +0.21% | +18.06% | +48.50% | 3.35TCr | |
| +1.19% | -4.98% | +26.31% | -0.76% | 2.4TCr | |
| -0.38% | +5.68% | +38.39% | +28.35% | 2.37TCr | |
| Average | +0.19% | +2.41% | +48.08% | +140.89% | 4.26TCr | |
| Weighted average by Cap. | +0.39% | +2.73% | +46.02% | +142.84% |
Employees
350
